Correction: Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source
Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. [PDF]
Giridhar A, Lekha T, Chandran K.
europepmc +1 more source
Assessing Polypoidal Choroidal Vasculopathy-Related OCT Features in the TENAYA and LUCERNE Trials. [PDF]
Teo KYC +7 more
europepmc +1 more source
Peripheral polypoidal choroidal vasculopathy
Tingkun Shi, Haoyu Chen
doaj +1 more source
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source
Polypoidal choroidal vasculopathy invading the optic disc
Alessandro Marchese +2 more
doaj +1 more source
Real-World Outcomes of Faricimab for Polypoidal Choroidal Vasculopathy in a Multi-ethnic Cohort: A 12-Month Retrospective Study. [PDF]
Fu DJ +7 more
europepmc +1 more source
Predictors of the early pneumatic displacement effect of submacular haemorrhage secondary to polypoidal choroidal vasculopathy. [PDF]
Zheng F +14 more
europepmc +1 more source
Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]
Jeong S, Seong SH, Sagong M.
europepmc +1 more source
Choroidal changes correlate with type 1 neovascular activity in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. [PDF]
Huang X +7 more
europepmc +1 more source

